Aquila Investment Management LLC Seagen Inc. Transaction History

Aquila Investment Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 23, 2023	SELL	$191.51 - $216.16 $766,040 - $864,640	-4,000 Reduced 57.14%	3,000 $636,000
Q2 2023 Jul 24, 2023	BUY	$187.64 - $206.25 $375,280 - $412,500	2,000 Added 40.0%	7,000 $1.35 Million
Q1 2023 Apr 26, 2023	SELL	$127.59 - $203.08 $255,180 - $406,160	-2,000 Reduced 28.57%	5,000 $1.01 Million
Q4 2022 Jan 30, 2023	SELL	$117.37 - $139.17 $234,740 - $278,340	-2,000 Reduced 22.22%	7,000 $899,000
Q3 2022 Oct 19, 2022	BUY	$135.27 - $180.11 $270,540 - $360,220	2,000 Added 28.57%	9,000 $1.23 Million
Q2 2022 Jul 19, 2022	BUY	$108.81 - $179.33 $326,430 - $537,990	3,000 Added 75.0%	7,000 $1.24 Million
Q4 2021 Feb 09, 2022	BUY	$142.57 - $190.86 $570,280 - $763,440	4,000 New	4,000 $618,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Aquila Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Aquila Investment Management LLC with notifications on news.